Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Leaven Partners Brent Jackson, CFA | “Manac Chemical Partners is a Japanese specialty chemical producer specializing in bromine and iodine chemistry. Its primary business lines include flame-retardant additives for electronics and automotive plastics, specialty ingredients for advanced electronic films, and active pharmaceutical intermediates. The manager initiated positions in late 2025 based on a compelling operational turnaround thesis. Manac possesses a durable competitive advantage derived from complex chemical synthesis capabilities and strategic integration with its largest shareholder and raw material supplier, Tosoh. The business demonstrates exceptional operating leverage, where moderate volume growth generates exponential operating earnings growth. In the recent quarter, an 18.4% increase in net sales catalyzed a near-quadrupling in operating profit to ¥371 million as operating margins surged from 3.8% to 11.8%, dramatically expanding return on invested capital. Key growth catalysts encompass sustained demand for high-performance electronic films, regulatory standards driving flame-retardant adoption, and shareholder-friendly capital allocation including dividend hikes. Key risks involve raw material pricing volatility from bromine feedstocks and cyclical slowdowns in global consumer electronics manufacturing.” | BULL | Q3 2026 Oct 1, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.